Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-23-061821
Filing Date
2023-05-17
Accepted
2023-05-17 16:05:40
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pmgmu-20220930x10q.htm   iXBRL 10-Q 880789
2 EXHIBIT 31.1 pmgmu-20220930xex31d1.htm EX-31.1 15711
3 EXHIBIT 31.2 pmgmu-20220930xex31d2.htm EX-31.2 13852
4 EXHIBIT 32.1 pmgmu-20220930xex32d1.htm EX-32.1 8936
5 EXHIBIT 32.2 pmgmu-20220930xex32d2.htm EX-32.2 8937
  Complete submission text file 0001104659-23-061821.txt   4848930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pmgmu-20220930.xsd EX-101.SCH 50640
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmgmu-20220930_cal.xml EX-101.CAL 27494
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgmu-20220930_def.xml EX-101.DEF 223834
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgmu-20220930_lab.xml EX-101.LAB 373548
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgmu-20220930_pre.xml EX-101.PRE 309528
47 EXTRACTED XBRL INSTANCE DOCUMENT pmgmu-20220930x10q_htm.xml XML 688387
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40021 | Film No.: 23931650
SIC: 2834 Pharmaceutical Preparations